Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 12 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 9 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

4(57.1%)

Phase 2

3(42.9%)

7Total

N/A(4)

Phase 2(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)

Showing 12 of 12 trials

NCT02300766Recruiting

Cerebellar Mutism Syndrome Study

Role: collaborator

NCT02881099Completed

Parkinson's Repository of Biosamples and Network Datasets (Tracking Parkinson's)

Role: lead

NCT00443768Completed

Medication Review in Patients on Anti-parkinson Therapy

Role: lead

NCT01693081Phase 2Completed

Phase IIa Multicentre Study Investigating of VR040 in Parkinson's Disease

Role: lead

NCT01683292Phase 2Completed

Single-Centre Study of VR040(Inhaled Apomorphine) in Idiopathic Parkinson's Disease

Role: lead

NCT00476892Not ApplicableCompleted

Multi-centre Randomised Controlled Trial of Pelvic Floor Muscle Training for Prolapse

Role: collaborator

NCT00466739Completed

European Compliance Study in Parkinson's Disease

Role: lead

NCT00245700Completed

Adherence of Stalevo, Entacapone and Levodopa

Role: lead

NCT00202631Not ApplicableUnknown

Abdominal Functional Electrical Stimulation in Tetraplegia

Role: lead

NCT00361205Not ApplicableCompleted

Electronic Compliance Monitoring in Parkinson's Disease

Role: lead

NCT00124826Phase 2Completed

SELESTIAL: Trial of Insulin to Control Blood Sugar After Acute Stroke Using Magnetic Resonance Imaging (MRI) End-Points

Role: collaborator

NCT00136071Not ApplicableUnknown

Transvaginal Tension Free Vaginal Tape-Obturator (TVT-O) Versus Transobturator Tape-Mentor (TOT) in the Management of Urodynamic Stress Urinary Incontinence

Role: lead

All 12 trials loaded